Cash Flow Statement

Takeda Pharmaceutical (TAK) Goodwill (2018 - 2026)

Takeda Pharmaceutical has reported Goodwill over the past 9 years, most recently at $37.0 billion for Q1 2026.

  • For Q1 2026, Goodwill rose 6.14% year-over-year to $37.0 billion; the TTM value through Mar 2026 reached $37.0 billion, up 6.14%, while the annual FY2026 figure was $38.6 billion, 10.4% up from the prior year.
  • Goodwill was $37.0 billion for Q1 2026 at Takeda Pharmaceutical, up from $34.9 billion in the prior quarter.
  • Across five years, Goodwill topped out at $37.9 billion in Q1 2022 and bottomed at $34.9 billion in Q1 2025.
  • The 5-year median for Goodwill is $36.5 billion (2024), against an average of $36.5 billion.
  • Year-over-year, Goodwill fell 4.51% in 2023 and then increased 6.14% in 2026.
  • Over 5 years, Goodwill stood at $37.9 billion in 2022, then fell by 4.51% to $36.2 billion in 2023, then grew by 0.8% to $36.5 billion in 2024, then dropped by 4.4% to $34.9 billion in 2025, then increased by 6.14% to $37.0 billion in 2026.
  • The last three reported values for Goodwill were $37.0 billion (Q1 2026), $34.9 billion (Q1 2025), and $36.5 billion (Q1 2024) per Business Quant data.